Cardana Caps


Une puissante formule ayurvédique pour la santé du cœur

  • Une combinaison des plantes ayurvédiques reconnues comme étant les plus efficaces pour la santé du cœur
  • Favorise le bon fonctionnement du cœur et des vaisseaux sanguins, une bonne circulation sanguine et une tension artérielle saine
  • Réduit les effets du stress sur le cœur
Sans Gluten
Sans OGM


En stock

If you decide a subscription is not for you, it can be cancelled after 30 days.

Bien que la récurrence des maladies cardiovasculaires augmente avec l’âge, elles ne constituent pas une conséquence inévitable du vieillissement. Cardana Caps est une formule à base de plantes ayurvédiques utilisée pour soutenir de la santé du cœur et du système vasculaire.

Cardana Caps contient cinq des herbes ayurvédiques les plus renommées utilisées pour apporter du soutien au système cardiovasculaire et pour maintenir une tension artérielle saine. Terminalia arjuna réduit la tension artérielle, la fréquence cardiaque et augmente la puissance des contractions cardiaques. Coleus forskohlii est un puissant vasodilatateur qui diminue la pression artérielle et améliore l’efficacité des contractions cardiaques. Crataegus laevigata (également connu sous le nom d’aubépine), augmente la force des contractions cardiaques, améliore la circulation sanguine, réduit le besoin en oxygène du muscle cardiaque et possède des propriétés antihypertensives et anti arythmiques. Boerhaavia diffusa est un diurétique qui aide à réduire la tension artérielle et un antioxydant qui protège les cellules du muscle cardiaque du stress oxydatif et de l’endommagement. Withania somnifera, plus connu sous le nom d’ashwagandha, favorise la santé cardiovasculaire en réduisant les effets du stress, notamment un pouls rapide et une pression artérielle élevée, et améliore l’endurance cardiorespiratoire.

Les personnes qui cherchent à maintenir une tension artérielle saine et à améliorer la fonction cardiaque globale pourront tirer profit de cette formule ayurvédique pour la santé du cœur.

Avantage AOR

Cardana Caps met en relief plusieurs plantes ayurvédiques traditionnelles et s’inscrit dans la philosophie d’AOR qui consiste à combiner plusieurs ingrédients aux mécanismes d’action variés pour une approche efficace, complète et sûre.




Formule à base de plantes utilisées en médicine ayurvédique traditionnelle pour favoriser la santé cardiovasculaire chez les adultes.


AOR™ certifie: Que tous les ingrédients sont mentionnés sur l’étiquette. Ne contient ni blé, ni gluten, ni noix, ni arachide, ni graine de sésame, ni sulfite, ni moutarde, ni soja, produit laitier, ni œuf, ni poisson, ni mollusque ou crustacé.

Posologie Adulte

Prendre une à deux capsules deux fois par jour entre les repas, ou selon les recommandations d’un professionnel de la santé. Prendre quelques heures avant ou après la prise d’autres médicaments ou produits de santé naturels. Utiliser pendant au moins deux mois afin de pouvoir observer les effets bénéfiques.

Mises en Garde

Ne pas utiliser ce produit si vous êtes enceinte ou si vous allaitez. Consulter un professionnel de la santé avant l’utilisation si vous prenez des glycosides cardiaques tels que la digitale/digoxine, des médicaments pour la tension artérielle, des diurétiques ou des anticoagulants. La consommation avec des breuvages alcoolisés ou d’autres médicaments ou de produits de santé naturels ayant des propriétés sédatives est déconseillée. Cesser l’utilisation en cas de gastrite légère, de constipation, de maux de tête ou de vomissements. Consulter un professionnel de la santé si les symptômes persistent ou s’aggravent ou si de nouveaux symptômes apparaissent.

Main Applications
  • Cardiovascular health
  • Blood pressure balance
  • Circulation
  • Oxygen sparing
  • Stress
Portion: une capsule
Terminalia arjuna (Arjuna)
113 mg
Crataegus laevigata (Aubépine, flavonoïde hyperoside 3,2
100 mg
Coleus forskohlii (Forskohlii, forskoline 10 %)
50 mg
Withania somnifera (Ashwaghanda)
Boerhaavia diffusa
50 mg

† Daily Value not established

Ingrédients non médicinaux : maltodextrine, cellulose microcristalline, dioxyde de silicium, stéarylfumarate de sodium et benzoate de sodium.

Capsule : hypromellose.

BackgroundAyurvedic Heart SupportMany Ayurvedic herbs have powerful medicinal effects that are not well known in North America. Cardana Caps encompasses the Ayurvedic herbs that have been traditionally used to support cardiovascular health, especially blood pressure, some of which have been well researched in Western medicine and found to clinically support the heart.1.) Terminalia arjuna bark. This Ayurvedic herb has been conclusively proven to have cardiovascular activity, helping to regulate blood pressure, slow the heart rate, and increase the force of the heart’s contractions.2.) Coleus forskohlii. Helps regulate blood pressure and increases the force of the heart’s contractions.3.) Crataegus laevigata (Hawthorn). Hawthorn, a plant used traditionally in Europe, is known for regulating blood pressure and plaque formation, and improving heart performance and metabolic parameters.4.) Withania somnifera. Also known as ashwagandha, it has been described as the most important medicinal plant in India, being a part of numerous Ayurvedic formulas. It is primarily used as an adaptogen for stress, and stress is a great risk factor for cardiovascular disease. Ashwagandha has been used as a treatment for the most debilitating diseases and is included for its cardioprotective and anti-stress activities.5.) Boerhaavia diffusa. Boerhaavia is a mild diuretic, helping to regulate blood pressure.Research1.) Terminalia arjuna bark. Studies have shown that extracts of Terminalia arjuna produce sustained hypotension and bradycardia which is dose-dependent. It has also been shown to increase the force of contraction of the heart in all doses. In a double-blind, placebo-controlled crossover study among heart patients, arjuna supplementation was able to ameliorate symptoms to such a degree that all patients had their conditions reclassified. Furthermore, arjuna increased the blood-pumping activity of their hearts by 10%, and the efficiency of those hearts at emptying blood out the left ventricle (ejection fraction) rose by nearly 20%. In the treatment of angina, studies have shown arjuna supplementation to be capable of reducing the frequency of attacks by two-thirds among stable angina patients. One study found that arjuna was as effective as isosorbide mononitrate (a common angina prevention medication) at reducing angina attacks and improving exercise capacity; patients also needed less isosorbide mononitrate when taking arjuna. Clinical trials have also been performed with heart attack patients with encouraging results.2.) Coleus forskohlii. Detailed pharmacologic studies established that forskolin – a diterpene lactone – positively influenced blood pressure in different animal species, as well as in humans. In addition, it improved contractions of the heart muscle. The blood pressure regulating effects of forskolin were attributed to a decrease in pre and after loads as well as decreased peripheral resistance by a direct action on relaxing the arteriolar smooth muscle. Both the improve heart contractility and the vascular effects were shown to be initiated by the stimulation of the membrane-bound enzyme adenylate cyclase resulting in raised intracellular cAMP levels, an activation of protein synthesis, a lowering of the membrane-bound Na , K -ATPase activity and activation of the slow calcium gate.3.) Crataegus laevigata (Hawthorn). The fruits from this plant act as a cardiotonic and coronary vasodilator. Hawthorn is reputed to promote the return to health of arteries. Various clinical studies have shown increased cardiac performance and output, decreases in peripheral resistance, pulmonary arterial and capillary pressures and blood pressure at rest and during exercise, and improved metabolic parameters. Recent human clinical studies have shown moderate decreases in LDL and non-HDL cholesterol, and slight decreases in diastolic blood pressure.4.) Withania somnifera. This herb has been the focus of hundreds of clinical studies and is one of the most exhaustively researched herbs. The anti-stress activity of the roots has been reported in multiple clinical studies. A small pilot study in humans over 30 days showed that ashwagandha reduced LDL cholesterol, VLDL cholesterol, and triglycerides, had diuretic activity which helps reduce blood pressure, and reduced blood glucose as well as a conventional hypoglycemic drug.5.) Boerhaavia diffusa. The cardiovascular action of this herb has been clinically studied. The rationale for its inclusion is due to its powerful diuretic activity which helps regulate blood pressure.Market TrendsOf these five herbs, Hawthorn is the most popular herbal supplement for cardiovascular protection. Hawthorn is known for regulating blood pressure and supporting arterial health.AOR AdvantageThis formula is in line with AOR’s philosophy: combining several ingredients that have multiple mechanisms of action for a more effective, well-rounded and safe approach rather than taking large doses of the same ingredient in the hopes of a greater effect. Cardana Caps also highlights several traditional Ayurvedic herbs.ReferencesAndallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol. 2000 Jun;38(6):607-9.Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. 2002 Mar-Apr;54(2):170-5.Bharani A, Ganguly A, Bhargava KD. (1995). “Salutray effect of T. Arjuna in patients with severe refactory heart failure”. Int. J. Cardiol. 49: 191-199.Blesher V.R. (1992). “Use of crataegus in cardiology. Fortscher Med. 15: 290-292.Divivedi, S. et al. (1995). “Term. arjuria and prostaglandin E activity”. Indian Drugs 24: 378-382.Heichrgens H. (1993). “Crataegus special extract WS 1442 in cardiac insuffiency NYH A II. A placebo-controlled randomized double blind study”. Fortschr Med. 111: 352-4.Loew, D. (1997). “Phytotheraphy in heart failure”. Phytomedicine. 4: 267-271.OÇonolly et al (1987). “Treatment of elderly, multimorbid patients with stenocardiac complaints with crateagus”. Therapiewoche. 37; 3587-3600.Reichert, R (1996). “Terminalia arjuna for Congestive heart failure:. Quarterly Rev. of Nat-Med Fall; 177-178.AbstractWithania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis.Mohanty IR, Arya DS, Gupta SK.Clin Nutr. 2008 Aug;27(4):635-42. Epub 2008 Jul 11.BACKGROUND AIMS: The present study was undertaken to evaluate the cardioprotective mechanisms of Withania somnifera (Ws), in the setting of ischemia and reperfusion (IR) injury.METHODS: Wistar rats were divided into three groups and received orally saline (sham, control IR) and Ws-50 mg/kg (Ws-IR), respectively, for 1 month. On the 31st day, in the rats of control IR and Ws-IR group, LAD coronary artery occlusion was undertaken for 45 min followed by 1 h reperfusion. Subsequently, all the animals were sacrificed for biochemical, immunohistochemical {Bax and Bcl-2 protein}, terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) positivity and histopathological studies.RESULTS: Post-ischemic reperfusion injury resulted in significant cardiac necrosis, apoptosis, decline in antioxidant status and elevation in lipid peroxidation in the IR control group as compared to sham. Ws prior-treatment favorably restored the myocardial oxidant-antioxidant balance, exerted marked anti-apoptotic effects {upregulated Bcl-2 (p<0.001) protein, decreased Bax (p<0.01) protein, and attenuated TUNEL positivity (p<0.01)}, and reduced myocardial damage as evidenced by histopathologic evaluation.CONCLUSIONS: The antioxidant and anti-apoptotic properties of Ws may contribute to the cardioprotective effects.Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.Indian Heart J. 2002 Mar-Apr;54(2):170-5.Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG.BACKGROUND: Terminalia arjuna, an Indian medicinal plant, has been reported to have beneficial effects in patients with ischemic heart disease in a number of small, open studies. The need for a double-blind, randomized, placebo-controlled study with adequate sample size has long been felt. The bark extract (IPC-53) contains acids (arjunic acid, terminic acid), glycosides (arjunetin arjunosides I-IV), strong antioxidants (flavones, tannins, oligomeric proanthocyanidins), minerals. etc. and exhibits antifailure and anti-ischemic properties.METHODS AND RESULTS: Fifty-eight males with chronic stable angina (NYHA class II-III) with evidence of provocable ischemia on treadmill exercise test received Terminalia arjuna (500 mg 8 hourly), isosorbide mononitrate (40 mg/daily) or a matching placebo for one week each, separated by a wash-out period of at least three days in a randomized, double-blind, crossover design. They underwent clinical, biochemical and treadmill exercise evaluation at the end of each therapy which were compared during the three therapy periods. Terminalia arjuna therapy was associated with significant decrease in the frequency of angina and need for isosorbide dinitrate (5.69 /-6.91 mg/week v. 18.22 /-9.29 mg/week during placebo therapy, p<0.005). The treadmill exercise test parameters improved significantly during therapy with Terminalia arjuna compared to those with placebo. The total duration of exercise increased (6.14 /-2.51 min v. 4.76 /-2.38 min, p<0.005), maximal ST depression during the longest equivalent stages of submaximal exercise decreased (1.41 /-0.55 mm v. 2.21 /-0.56 mm, p<0.005), time to recovery decreased (6.49 /-2.37 min v. 9.27 /-3.39 min, p<0.005) and higher double products were achieved (25.75 /-4.81×10(3) v. 23.11 /-4.83×10(3), p<0.005) during Terminalia arjuna therapy. Similar improvements in clinical and treadmill exercise test parameters were observed with isosorbide mononitrate compared to placebo therapy. No significant differences were observed in clinical or treadmill exercise test parameters when Terminalia arjuna and isosorbide mononitrate therapies were compared. No significant untoward effects were reported during Terminalia arjuna therapy.CONCLUSIONS: Terminalia arjuna bark extract, 500 mg 8 hourly, given to patients with stable angina with provocable ischemia on treadmill exercise, led to improvement in clinical and treadmill exercise parameters as compared to placebo therapy. These benefits were similar to those observed with isosorbide mononitrate (40 mg/day) therapy and the extract was well tolerated. Limitations of this study include applicability of the results to only men with chronic stable angina but not necessarily to women, as they were not studied.Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root.Indian J Exp Biol. 2000 Jun;38(6):607-9.Andallu B, Radhika B.Hypoglycemic, diuretic and hypocholesterolemic effects of roots of W. somnifera (ashvagandha) were assessed on human subjects. Six mild NIDDM subjects and six mild hypercholesterolemic subjects were treated with the powder of roots of W. somnifera for 30 days. Suitable parameters were studied in the blood and urine samples of the subjects along with dietary pattern before and at the end of treatment period. Decrease in blood glucose was comparable to that of an oral hypoglycemic drug. Significant increase in urine sodium, urine volume, significant decrease in serum cholesterol, triglycerides, LDL (low density lipoproteins) and VLDL (very low density lipoproteins) cholesterol were observed indicating that root of W. somnifera is a potential source of hypoglycemic, diuretic and hypocholesterolemic agents. Clinical observations revealed no adverse effects.Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy–a comparative study with dobutamine and sodium nitroprusside.Baumann G, Felix S, Sattelberger U, Klein G.J Cardiovasc Pharmacol. 1990 Jul;16(1):93-100.Forskolin, a diterpene derivative of the Indian plant Coleus forskhohlii, proved to be a marked positive inotropic and vasodilatory compound in animal experiments with a mechanism of action distinct from catecholamines, cardiac glycosides, and phosphodiesterase-inhibiting compounds. The cardiovascular effects of forskolin seem to be mediated by a direct stimulatory action at the catalytic unit of sarcolemmal adenylate cyclase. The aim of the present study was to clarify the cardiovascular profile of this compound in 12 patients with stage III (NYHA) congestive cardiomyopathy. The effects of forskolin were investigated by invasive techniques using the thermodilution catheter method and compared to the beta 1-receptor agonist dobutamine and the vasodilator sodium nitroprusside in an intraindividual comparison. Forskolin dose-dependently reduced cardiac pre- and afterload values, and led to a reduction in systolic, diastolic, and mean pulmonary artery pressure as well as pulmonary wedge pressure by greater than 50% concomitant with an increase in cardiac output. There was a slight increase in heart rate. Cardiac stroke volume and stroke volume index was increased by approximately 70%. The cardiovascular effects of dobutamine and nitroprusside were less pronounced; however, it seemed that a similar hemodynamic profile could be achieved by the combination of both dobutamine and sodium nitroprusside. In view of the rapid development of tolerance toward beta 1-receptor stimulation, forskolin, with its receptor-independent mechanism of action, may be advantageous for…..